NEWS
UK health regulator approves GSK’s vaccine for common respiratory virus RSV
Published On :
(Reuters) -Britain’s health regulator approved GSK’s vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually, the drugmaker said on Monday.
The Medicines and Healthcare products Regulatory Agency (MHRA) authorised GSK’s shot, called Arexvy, for active immunisation to prevent lower respiratory tract disease caused by RSV in adults 60 years and older, the company said.
RSV typically causes cold-like symptoms but is a leading cause of pneumonia in toddlers and the elderly.
The complex molecular structure of the virus and safety concerns with previous vaccine attempts had stymied efforts to successfully develop a shot since the virus was first discovered in 1956.
Arexvy has recently got the green light from the United States and European regulators.
(Reporting by Eva Mathews in Bengaluru; Editing by Savio D’Souza and Dhanya Ann Thoppil)
Uma Rajagopal has been managing the posting of content for multiple platforms since 2021, including Global Banking & Finance Review, Asset Digest, Biz Dispatch, Blockchain Tribune, Business Express, Brands Journal, Companies Digest, Economy Standard, Entrepreneur Tribune, Finance Digest, Fintech Herald, Global Islamic Finance Magazine, International Releases, Online World News, Luxury Adviser, Palmbay Herald, Startup Observer, Technology Dispatch, Trading Herald, and Wealth Tribune. Her role ensures that content is published accurately and efficiently across these diverse publications.
-
-
TECHNOLOGY4 days ago
CFE Finance Group acquires 100% of TechStar, a leader in the Metaverse A €6 million investment in the Meta Presence® platform
-
-
-
BUSINESS4 days ago
Walmart, other US retailers import fewer Christmas goods ahead of tepid holiday season
-
-
-
BUSINESS3 days ago
NEW LEADERSHIP TEAM DRIVES MAJOR YEAR-ON-YEAR GROWTH AT INFINOX CAPITAL LIMITED
-
-
-
INVESTING3 days ago
Integrity360 enables organisations to fully optimise their AI investment with launch of Managed dSOC Services underpinned by Darktrace’s ActiveAI Security Platform
-